Profound Medical and Akumin Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO®
May 06, 2021 07:00 ET
|
Profound Medical Corp.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow
April 21, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference
April 14, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors
March 03, 2021 07:00 ET
|
Profound Medical Corp.
TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results
March 02, 2021 16:02 ET
|
Profound Medical Corp.
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in March Virtual Investor Conferences
February 25, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 11, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
February 09, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues
January 05, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®
December 21, 2020 07:30 ET
|
Profound Medical Corp.
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...